Carregant...
Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...
Guardat en:
| Publicat a: | JRSM Cardiovasc Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359167/ https://ncbi.nlm.nih.gov/pubmed/26668738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2048004015576008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|